Idenix Pharma (IDIX) Resumes Trading, Down 24%
Idenix Pharmaceuticals (Nasdaq: IDIX) resumes trading, now down 24 percent early.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Navidea Biopharma (NAVB) Awarded $1.8M Fast-Track SBIR for Manocept Immunotherapeutics Evaluation in Kaposi’s Sarcoma
- Paragon Shipping (PRGN) Receives Nasdaq Listing Notification; Will Begin Trading OTC Under 'PRGNF'
- SMART Technologies (SMT) Halted, News Pending
Create E-mail Alert Related CategoriesTrading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!